Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1996-10-07
1998-07-07
Walsh, Stephen
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
536 235, C12Q 168, C12N 1510
Patent
active
057766908
ABSTRACT:
Chronic fatigue syndrome in an individual is diagnosed by determining the level of RNase L inhibitor mRNA or protein in peripheral blood mononuclear cells. Significantly decreased levels of RLI mRNA or protein compared to healthy control individuals indicates the presence of chronic fatigue syndrome.
REFERENCES:
patent: 5258369 (1993-11-01), Carter
Bleijenberg et al., Enteroviruses and the chronic fatigue syndrome, Clinical Infect. Dis., 19:860-864; Nov. 1994.
Honda et al., Japanese patients with chronic fatigue syndrome are negative for known retroviruses, Microbiol. Immunol., 37(10): 779-784. Dec. 1993.
Suhadolnik et al., Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome, In Vivo, 8: 599-604, Nov. 1994.
E. Barker, et al. (1994), Immunologic abnormalities associated with chronic fatigue syndrome. Clinical Infectious Diseases 18 (Suppl. 1):S136-41.
M. Becker-Andre, et al. (1989), Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Research, 17(22):9437-9446.
C. Bisbal, et al. (1995), Cloning and characterization of a RNase L inhibitor. The Journal of Biological Chemistry 270(22):13308-13317.
D. Ferbus, et al. (1981). The 2'5' oligoadenylate synthease has a multifunctional 2'5' nucleotidyl-transferase activity. Biochemical and Biophysical Research Communications 100(2):847-856.
G. Floyd-Smith, et al. (1981), Interferon action: RNA cleavage pattern of a (2'-5') oligoadenylate-dependent endonuclease. Science212:1030-1032.
K. Fukuda, et al. (1994), The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 121(12):953-959.
G. Gilliland, et al. (1990), Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:2725-2729.
Immunosciences Lab., Inc. (approx. Jun. 1995), new product announcement.
N.G. Klimas, et al. (1990), Immunologic abnormalities in chronic fatigue syndrome. Journal of a Clinical Microbiology 28(6):1403-1410.
P. Lengyel (1993), Tumor-suppressor genes: news about the interferon connection, Proc. Natl. Acid. Sci. USA 90:5893-5895.
T. Lion (1994), Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. Bone marrow Transplantation 14:505-509.
E. Mordechai, et al. (1995), Activation of the interferon-inducible enzymes, 2', 5'-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I rex-response element. Virology 206:913-922.
L.J.A. Morrison. et al. (1991), Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin. exp. Immunol. 83:441-446.
S. Pestka. et al. (1987), Interferons and their actions. Ann Rev. Biochem. 56:727-777.
T. Salehzada, et al. (1983), 2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits. The Journal of Biological Chemistry 268(11):7733-7740.
P.D. Siebert, et al. (1983), PCR Mimics: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 14(2):244-249.
R.H. Silverman, et al. (1982), Control of the ppp(A2'p).sub.n. A system in Hela cells. Eur. J. Biochem. 124:131-138.
R.J. Suhadolnik, et al. (1994), Upregulation of the 2-5A synthetase/RNase l antiviral pathway associated with chronic fatigue syndrome. Clinical Infectious Diseases 18(Suppl. 1):S96-104.
D.H. Wreschner, et al. (1981), Interferon action-sequence specificity of the ppp(A2' P).sub.n A-dependent ribounclease, Nature289:414-417.
A. Zhou, et al. (1993), Epression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72:753-765.
Mordechai Eli
Vojdani Aristo
Kaufman Claire M.
Walsh Stephen
LandOfFree
Detection of chronic fatigue syndrome by decreased levels of RNa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of chronic fatigue syndrome by decreased levels of RNa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of chronic fatigue syndrome by decreased levels of RNa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1204112